Accreditation
In support of improving patient care, this activity has been planned and implemented by Dartmouth Health
and The Obesity and Metabolism Institute LLC. Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
American Medical Association (AMA)
Dartmouth Health designates this live activity for a maximum of 65.25 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: All other learners may claim CME-designated participation credit. Consult your professional
licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.
Learning Objectives
At the conclusion of this learning activity, participants will be able to:
Determine the mechanism of action and most effective use of current and emerging pharmacological,
endoscopic, and medical device-based treatments for obesity.
Apply a greater understanding of the pathophysiology of obesity and its metabolic consequences to
improve the care of patients with these disorders.
Assess patients for their need and appropriateness for lifestyle-based therapies for obesity, including
dietary manipulation, optimizing physical activity, stress reduction, improved sleep health, and circadian
rhythm preservation.